Although the dynamics of immunomodulation of free Hb and heme differ slightly in the central nervous system (CNS) because of the blood–brain barrier, patients with SCD are at a greater risk for acute or chronic ischemic CNS events [40,41,42,43]. The gene discussed is GSTM1; the disease is Schnyder corneal dystrophy.